Outcomes of women presenting in active versus latent phase of spontaneous labor.

OBJECTIVE: To evaluate outcome differences between women presenting in latent and active labor. METHODS: We evaluated all low-risk women with term, singleton, vertex gestations who presented in active phase or latent phase labor at MetroHealth Medical Center from January 1993 to June 2001. Baseline characteristics were compared. Labor outcomes were assessed by logistic regression, controlling for parity. RESULTS: A total of 6,121 active phase and 2,697 latent phase women met the study criteria. More latent phase women were nulliparous (51 compared with 28%). Latent phase women had more cesarean deliveries (nulliparas 14.2% compared with 6.7%, multiparas 3.1% compared with 1.4%). Controlling for parity, latent phase women had more active phase arrest (odds ratio [OR] 2.2), oxytocin use (OR 2.3), scalp pH performed (OR 2.2), intrauterine pressure catheter placed (OR = 2.2), fetal scalp electrocardiogram monitoring (OR = 1.7), and amnionitis (OR 2.7) (P < .001 for each). CONCLUSION: It is uncertain whether inherent labor abnormalities resulted in latent phase presentation and subsequent physician intervention or early presentation and subsequent physician intervention are the cause of labor abnormalities.

Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes.

OBJECTIVE: The purpose of this study was to correlate low maternal pregravid weight, delivery weight, and poor gestational weight gain with perinatal outcomes. STUDY DESIGN: Maternal and perinatal data from January 1997 to June 2001 were obtained from a perinatal database at MetroHealth Medical Center. Low maternal weight (LMW) was defined as pregravid or delivery weight <100 pounds or body mass index (BMI) < or =19.8 kg/m(2). Low maternal weight gain was defined as <0.27 kg per week. Perinatal complication rates in these subjects were compared with those with weights of 100 to 200 pounds, normal BMI (>19.8, <26 kg/m(2)), and normal gestational weight gain (0.27-0.52 kg/wk). Chi-square and t tests were used where appropriate. P<.05 was significant. RESULTS: A percentage (2.6%) of 15,196 subjects began pregnancy weighing < or =100 pounds; 0.15% weighed <100 pounds at delivery and 13.2% had a pregravid BMI < or =19.8 kg/m(2). Pregravid LMW was highly correlated with ethnicity (Asians, 8.6%; Hispanics, 4.3%; Caucasians, 2.5%; African Americans, 1.9%; P<.001). Subjects with pregravid LMW were at increased risk for intrauterine growth restriction (IUGR) (relative risk [RR], 2.3, 95% CI, 1.3-4.05), and perineal tears (3rd-degree lacerations; RR, 1.8, 95% CI, 1.1-2.9), and low birth weight ([LBW] <2500 g; RR, 1.8, 95% CI, 1.1-2.9). They had a lower risk of cesarean section (RR, 0.72, 95% CI, 0.56-0.92) and preterm delivery (PTD) (RR, 1.1, 95% CI, 0.97-1.06). Pregravid BMI <19.8 kg/m(2) was associated with preterm labor (PTL) (RR, 1.22, 95% CI, 1.02-1.46), IUGR (RR, 1.67, 95% CI, 1.2-2.39), and LBW (<2500 g; RR, 1.13, 95% CI, 1.0-1.27) and was protective against cesarean delivery (RR, 0.8, 95% CI, 0.71-0.91). Delivery LMW was associated with LBW (<2500 g; RR, 2.81, 95% CI, 1.62-4.84), active-phase arrest (RR, 5.07, 95% CI, 1.85-13.9), PTL and PTD (RR, 2.5, 95% CI, 1.02-6.33, and RR, 2.45, 95% CI, 1.4-4.4, respectively), a lower gestational age at delivery (36.8 vs 38.3 wks, P<.05), and mediolateral episiotomy (RR, 9.6, 95% CI, 1.9-48.0). A percentage (0.8%) of subjects had BMI <19.8 kg/m(2) at delivery. Low delivery BMI was associated with birth weight <2500 g (RR, 1.74, 95% CI, 1.3-2.32), PTL (RR, 2.16, 95% CI, 1.45-3.19), and PTD (RR, 1.57, 95% CI, 1.18-2.11). Failure to thrive in pregnancy (weight gain <0.27 kg/wk) was associated with LBW (<1500 g; RR, 1.23, 95% CI, 1.03-1.45), <2500 g; RR, 1.22, 95% CI, 1.13-1.33), and PTL and PTD (RR, 1.2, 95% CI, 1.05-1.37, and RR, 1.11, 95% CI, 1.02-1.2, respectively). CONCLUSION: Low weight and BMI at conception or delivery, as well as poor weight gain during pregnancy, are associated with LBW, prematurity, and maternal delivery complications.

Fetal cyclic motor activity in diabetic pregnancies: sensitivity to maternal blood glucose.

Spontaneous fetal movement in the last third of human gestation is dominated by irregular oscillations on a scale of minutes (cyclic motility, CM). The core properties of these oscillations are stable during the third trimester of gestation in normal fetuses, but disrupted by poorly controlled maternal diabetes. Here we investigated whether fetal CM is linked to short-term instabilities in maternal glucose metabolism. The fetuses of 40 mothers with type I (n = 28) or gestational (n = 12) diabetes were studied one to six times between 27 and 40 postmenstrual weeks of gestation. Fetal movement and maternal blood glucose concentration were measured during two separate periods of fetal activity in each session. Fetal CM was quantified with spectral analysis. Early in the third trimester, changes in the rate of oscillation in fetal CM between the two periods of activity were inversely related to changes in maternal blood glucose levels. Fetal CM was unrelated to concurrent maternal blood glucose levels at any point in the third trimester. The pattern of results suggests that disruption of the temporal organization of spontaneous fetal motor activity in pregnancies complicated by maternal diabetes represents an acute response to fluctuations in the metabolic environment rather than an alteration of CM development.

Serine metabolism in human pregnancy.

Serine plays an important role in intermediary metabolism as a source of one carbon pool for nucleotide biosynthesis, as a precursor for glycine and glucose, and as a contributor to cysteine biosynthesis. A unique serine-glycine cycling between the liver and the placenta has been demonstrated in the sheep fetus. We hypothesized that, because of serine's role in growth and development, significant changes in serine metabolism will occur in pregnancy with advancing gestation. The rate of appearance (R(a)) of serine and its metabolism were quantified in healthy women longitudinally through pregnancy with a [2-(15)N(13)C]serine tracer. The contribution of serine N to urea and the rate of oxidation of serine were measured using the precursor-product relation. Plasma serine concentrations and serine R(a) were lower in pregnant (P) women, in both early and late gestation, compared with nonpregnant (NP) women [plasma serine: NP, 113 +/- 24.5; P early, 71.9 +/- 6.2; P late, 68.5 +/- 9.6 micromol/l; serine R(a): NP (n = 7), 152.9 +/- 42.8; P early (n = 12), 123.7 +/- 21.5; P late (n = 8), 102.8 +/- 18.2 micromol x kg(-1) x h(-1)]. Serine contributed approximately 6% to urea N and 15-20% to the plasma glycine pool, and oxidation of serine represented approximately 8% of R(a). There was no significant difference between P and NP subjects. Glucose infusion, at 3 mg x kg(-1) x min(-1) in P subjects, resulted in a decrease in serine R(a) and an increase in oxidation. The decrease in serine turnover in pregnancy may represent a decrease in alpha-amino nitrogen turnover related to a decreased rate of branched-chain amino acid transamination and caused by pregnancy-related hormones aimed at nitrogen conservation and accretion.

Prevalence of maternal obesity in an urban center.

OBJECTIVE: The purpose of this study was to evaluate the changing prevalence of maternal obesity in an urban center. STUDY DESIGN: The prevalence of obesity in 31,542 pregnancies from January 1986 to December 1996 (group 1) was compared with the prevalence of obesity in 15,600 pregnancies between January 1997 and June 2001 (group 2). Maternal weight was divided into two groups according to measurements performed at delivery (200 pounds). Women who weighed >or=200 pounds were divided into subgroups for analysis (201-250 pounds, 251-300 pounds, and >300 pounds). The incidence of obesity by weight group was evaluated for a change over time; the impact of race and socioeconomic status was analyzed. A probability value of <.05 was considered significant. RESULTS: Maternal obesity was significantly more common in group 2 (>200 pounds: 28% vs 21%; relative risk, 1.3; 95% CI, 1.3-1.4; 201-250 pounds: 20% vs 16%; relative risk, 1.3; 95% CI, 1.2-1.3; 251-300 pounds: 5.5% vs 3.7%; relative risk, 1.5; 95% CI, 1.3-1.6; >300 pounds: 1.6% vs 1.2%; relative risk, 1.4; 95% CI,1.2-1.7; P <.001 for each). Obesity was most common in African American women (>200 pounds, 28.1%; 201-250 pounds, 20.5%; 251-300 pounds, 5.5%; and >300 pounds, 2.1 %). The prevalence of obesity increased most among African American women (>200 pounds: 35 % vs 25%; relative risk, 1.4; 95% CI, 1.4-1.5; 201-250 pounds: 25 % vs 18%; relative risk, 1.4; 95% CI, 1.3-1.5; 251-300 pounds: 7.3 % vs 4.6%; relative risk, 1.6; 95% CI, 1.4-1.6; >300 pounds: 2.7% vs 1.8%; relative risk, 1.5; 95% CI, 1.3-1.9; P <.001 for each), and it decreased in Asian women (>200 pounds: 6.8% vs 11%; relative risk, 0.6; 95% CI, 0.4-0.9; P <.05; 201-250 pounds: 6.3% vs 9.7%; relative risk, 0.6; 95% CI, 0.4 -1.1; P >.05; 251-300 pounds: 0.6% vs 1%; relative risk, 0.6; 95% CI, 0.1- 2.9; P >.05; >300 pounds: 0.0% vs 0.3%). The increase in weight over time remained statistically significant after being controlled in multivariate analysis for socioeconomic status and race. Women with milder obesity (201-250 pounds prepregnancy weight) were at increased risk for preeclampsia, gestational and insulin-dependent diabetes mellitus, advanced gestational age (>or=42 weeks), fetal macrosomia, and cesarean delivery (P <.001 for each), with increasing weight being associated with higher risk. CONCLUSION: Obesity that complicates pregnancy has increased significantly over the past 15 years. The risk of perinatal complications increases with increasing maternal pregravid weight; even those women with moderate obesity are at increased risk of adverse outcomes.